Top global partnering event; thousands of 1:1 meetings with pharma BD teams; best for out-licensing innovative assets.

Major oncology data event; key trigger for licensing discussions and pharma interest in innovative assets.

Highly efficient partnering system; one of the best EU platforms for out-licensing and deal execution.

Important for metabolic assets; targeted BD discussions with pharma leaders in obesity/diabetes.

Highest concentration of big pharma executives and BD heads; prime environment for high-value licensing, strategic partnerships, and investor-driven dealmaking.

Direct access to Japanese pharma (very active in in-licensing); strong for regional licensing and co-development deals.

BIO-Europe Spring is Europe's largest springtime biotech partnering event, bringing together over 3,700 leaders and innovators in the life sciences industry. It's designed for partnering, business development, and licensing opportunities in biotechnology and pharmaceuticals.